Natural Alternatives (NAII) director granted 8,000 restricted shares
Rhea-AI Filing Summary
Dunn Alan G reported acquisition or exercise transactions in this Form 4 filing.
Natural Alternatives International director Alan G. Dunn received a grant of 8,000 shares of Common Stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. One-third vests on March 7, 2027, another third on March 7, 2028, and the final third on March 7, 2029. Following this award, he directly holds 99,211 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 8,000 shares
Net Buy
1 txn
Insider
Dunn Alan G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 8,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 99,211 shares (Direct)
Footnotes (2)
- F1. This transaction represents a grant of restricted stock to an outside Director pursuant to the Issuer's 2020 Omnibus Incentive Plan.
- F2. One third (2,667 shares) of the restricted stock vests on March 7, 2027; one third (2,667 shares) of the restricted stock vests on March 7, 2028, and the final third (2,666 shares) of the restricted stock vests on March 7, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did NAII director Alan G. Dunn report?
Director Alan G. Dunn reported receiving 8,000 shares of NAII Common Stock as a restricted stock award. The grant was issued at no cash cost to him under the company’s 2020 Omnibus Incentive Plan as part of his director compensation.
Was the NAII Form 4 transaction an open-market purchase or sale?
The transaction was not an open-market trade. It reflects a compensation-related grant of 8,000 restricted shares to an outside director, recorded with transaction code “A” for grant or award, at a reported price per share of $0.0000.